Article
Exploring evidence of SGLT2 inhibitors use in Southeast Asia: a systematic review
2025-07-03
Abstract excerpt
<h4>Background</h4> The benefits of sodium glucose cotransporter 2 (SGLT2) inhibitors are increasingly recognized, not only in the management of diabetes but also in cardiovascular and renal conditions. However, evidence regarding SGLT2 inhibitor use in Southeast Asian populations remains limited and has yet to be systematically reviewed. <h4>Methods</h4> A systematic literature search was conducted in Ovid Medl...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2507bc48-0853-5333-9456-c255a08a111c
- DOI
- 10.1101/2025.07.02.25330722
